News

A new study has revealed how the protein Rab7a enhances the activity of TPC2, a cellular channel linked to melanoma, the deadliest form of skin cancer.

Medical cannabis, a widely debated topic, took center stage at the ACR Convergence 2024, where researchers explored its role in managing chronic pain related to rheumatic diseases.

A recent analysis of the IDEAL clinical trial highlights a breakthrough for early-stage breast cancer.

Patients with multiple sclerosis (MS) may experience a slightly increased risk of developing cancer compared to the general population, according to a new nationwide French study spanning 10 years.

Obstructive sleep apnea (OSA) severity may hold the key to predicting postoperative cardiorespiratory complications, according to a new study involving over 6,700 patients.

A cutting-edge alternative to traditional skin creams offers a promising new approach for treating inflammatory skin diseases.

Sodium channels in cartilage cells may hold the key to treating osteoarthritis (OA), a new study presented at ACR Convergence 2024 unveiled.

Control over clinical work plays a critical role in preventing burnout and retaining U.S. physicians, as highlighted in a new study.

Mailed fecal immunochemical testing (FIT) kits using centralized outreach significantly increases colorectal cancer (CRC) screening rates in underserved communities, according to the results of a new study.

Clonazepam has been recalled due to potential product carton strength mislabeling. Endo Pharmaceuticals (Malvern, Pennsylvania) has issued a voluntary, nationwide recall of a specific lot of Clonazepam Orally Disintegrating Tablets (USP, C-IV).

Bias in medical artificial intelligence (AI) poses a critical threat to equitable patient outcomes, according to recent research.

The response to tamoxifen, a cornerstone drug in preventing breast cancer recurrence, may hinge on an unexpected factor: gut bacteria.

Pulmonary arterial hypertension (PAH), a rare yet life-threatening vascular condition, predominantly affects older adults and women, according to new findings from the Global Burden of Disease Study 2021.

Pandrug-resistant Klebsiella pneumoniae strains isolated from Ukrainian war victims are raising red flags for healthcare professionals worldwide.

Long-term cognitive and psychosocial challenges faced by individuals recovering from anti-NMDAR encephalitis, despite many regaining independence, have been highlighted in a recent study.

The way couples manage stress together profoundly impacts outcomes for patients with rheumatoid arthritis (RA), according to a new study.

Results from the Phase III ICONIC-LEAD trial reveal that JNJ-2113 (icotrokinra, Johnson & Johnson, New Jersey), an oral peptide targeting the IL-23 receptor, demonstrated improvements in skin clearance among patients with moderate to severe plaque psoriasis.

Even healthy breast tissue harbors rare populations of mutated epithelial cells, raising important questions about their role in breast cancer development.

In a recent study, researchers found that interstitial lung abnormalities (ILAs), early indicators of interstitial lung disease, were present in 1.7% of routine abdominal and thoracoabdominal CT scans from unselected patients.

The treatment landscape for juvenile idiopathic arthritis (JIA) has shifted significantly over the past two decades, according to a new study analyzing DMARD (disease-modifying antirheumatic drug) utilization among commercially insured children in the United States from 2001 to 2022.

A new study in the UK Biobank suggests that high cardiorespiratory fitness (CRF) can significantly reduce dementia risk and delay its onset, even in individuals with a genetic predisposition to the condition.

A significant risk associated with immune checkpoint inhibitors (ICIs), a class of cancer therapies, has been identified in a new study.

A randomized clinical trial has revealed that pharmacological ascorbate (high-dose intravenous vitamin C) improves survival outcomes for patients with metastatic pancreatic cancer, a disease with notoriously low 5-year survival rates.

Respiratory syncytial virus (RSV) is a significant health concern for adults, contributing to thousands of hospitalizations annually.